Live Breaking News & Updates on Director Karen Prange

Stay updated with breaking news from Director karen prange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AtriCure, Inc. (NASDAQ:ATRC) Receives $66.80 Average PT from Brokerages

AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given an average recommendation of “Buy” by the four analysts that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued ratings on the stock in the last […] ....

United States , Hong Kong , Piper Sandler , Stifel Nicolaus , Karen Prange , Karls Dahlquist , Needham Company , Almanack Investment Partners , Hong Kong Ltd , Atricure Inc , Atricure Company Profile , Get Free Report , Marketbeat Ratings , Director Karen Prange , Investment Partners , Kong Ltd , Get Free , Isolator Synergy Clamps , Atricure Daily , Nasdaq Atrc ,

Advisors Capital Management LLC Raises Stock Position in AtriCure, Inc. (NASDAQ:ATRC)

Advisors Capital Management LLC lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 25.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,208 shares of the medical device company’s stock after acquiring an additional 11,529 shares during the […] ....

United States , Hong Kong , Piper Sandler , Stifel Nicolaus , Maggie Yuen , Karen Prange , Needham Company , Exchange Commission , Atricure Inc , Almanack Investment Partners , Hong Kong Ltd , Atricure Company Profile , Advisors Capital Management , Free Report , Capital Management , Investment Partners , Kong Ltd , Quantbot Technologies , Get Free Report , Director Maggie Yuen , Director Karen Prange , Isolator Synergy Clamps , Visit Holdingschannel , Atricure Daily , Nasdaq Atrc , Sec Filings ,

AtriCure (NASDAQ:ATRC) Price Target Increased to $65.00 by Analysts at Piper Sandler

AtriCure (NASDAQ:ATRC – Free Report) had its price objective increased by Piper Sandler from $55.00 to $65.00 in a research note published on Wednesday morning, FlyOnTheWall reports. ATRC has been the subject of several other research reports. Needham & Company LLC upped their target price on shares of AtriCure from $60.00 to $68.00 and gave […] ....

United States , Piper Sandler , Karen Prange , Karls Dahlquist , Stifel Nicolaus , Needham Company , Atricure Inc , Dimensional Fund Advisors , Invesco Ltd , Securities Exchange Commission , Norges Bank , First Light Asset Management , Free Report , Moderate Buy , Get Free Report , Director Karen Prange , Exchange Commission , Light Asset Management , Fund Advisors , Isolator Synergy Clamps , Atricure Daily , Nasdaq Atrc , Boost Price Target ,

AtriCure, Inc. (NASDAQ:ATRC) Stock Holdings Lifted by Emerald Mutual Fund Advisers Trust

Emerald Mutual Fund Advisers Trust raised its position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 1.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 411,400 shares of the medical device company’s stock after purchasing an additional 5,700 shares during […] ....

United States , Stifel Nicolaus , Karls Dahlquist , Piper Sandler , Karen Prange , Exchange Commission , Metlife Investment Management , Atricure Inc , Needham Company , Alphacrest Capital Management , Dimensional Fund Advisors , Emerald Mutual Fund Advisers , Sei Investments Co , Securities Exchange Commission , Financial Services Group Inc , Emerald Mutual Fund Advisers Trust , Free Report , Mutual Fund Advisers Trust , Services Group , Crest Capital Management , Life Investment Management , Fund Advisors , Sei Investments , Get Free Report , Director Karen Prange , Isolator Synergy Clamps ,

AtriCure (NASDAQ:ATRC) Posts Quarterly Earnings Results, Beats Expectations By $0.15 EPS

AtriCure (NASDAQ:ATRC – Get Free Report) announced its quarterly earnings results on Tuesday. The medical device company reported ($0.12) EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.15, Briefing.com reports. The firm had revenue of $100.92 million during the quarter, compared to analysts’ expectations of $97.55 million. AtriCure had a negative net […] ....

United States , Stifel Nicolaus , Piper Sandler , Karen Prange , Karls Dahlquist , Dimensional Fund Advisors , Sei Investments Co , Atricure Inc , Needham Company , Atricure Company Profile , Financial Services Group Inc , Alphacrest Capital Management , Metlife Investment Management , Securities Exchange Commission , Get Free Report , Director Karen Prange , Exchange Commission , Services Group , Crest Capital Management , Life Investment Management , Fund Advisors , Sei Investments , Isolator Synergy Clamps , Atricure Daily , Nasdaq Atrc ,